Phosphatidylinositol 3-kinase isoforms as targets in respiratory disease
Respiratory diseases such as chronic obstructive pulmonary disease [COPD], severe asthma, cystic fibrosis [CF] and idiopathic pulmonary fibrosis [IPF] are inadequately controlled by current therapies. The underlying molecular mechanisms and pathogenesis of these diseases remain unclear, making ident...
Main Authors: | John A. Marwick, Kian Fan Chung, Ian M. Adcock |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2010-02-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753465809352792 |
Similar Items
-
Inhibitory Activity of Flavonoids against Class I Phosphatidylinositol 3-Kinase Isoforms
by: Yanwen Zhang, et al.
Published: (2011-06-01) -
The Role of Phosphatidylinositol-3 Kinases and Phosphatidylinositol Phosphatases in T Cell Intracellular Homeostasis and Autophagy
by: McLeod, Ian Alexander
Published: (2013) -
Study of nuclear targets of phosphatidylinositol-3 kinase in lymphocytes
by: Shore, Angharad Mair
Published: (2006) -
Regulation of the Target of Rapamycin and Other Phosphatidylinositol 3-Kinase-Related Kinases by Membrane Targeting
by: Maristella De Cicco, et al.
Published: (2015-09-01) -
Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important?
by: Célia Cintas, et al.
Published: (2018-01-01)